Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator

Xiao Feng(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhong Chen(Sun Yat-sen University), Yu Zhou(Anhui Medical University), Xiaoli Chen(Air Force Medical University), Na Liu(Qingdao University), Lei Zhang(Institute of Hematology & Blood Diseases Hospital), Zhongchao Han(Amgen (United States)), Zhi Bo Han(Chinese Academy of Medical Sciences & Peking Union Medical College)
Human Immunology
December 1, 2007
10.1016/j.humimm.2007.10.004
Cited by 43

Related Papers

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
|PubMed|2001|479
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes
|Nature Genetics|2015|400